The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Soluble Urokinase Receptor and Chronic Kidney Disease
Open accessAbstract
BACKGROUND: Relatively high plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) have been associated with focal segmental glomerulosclerosis and poor clinical outcomes in patients with various conditions. It is unknown whether elevated suPAR levels in patients with normal kidney function are associated with future decline in the estimated glomerular filtration rate (eGFR) and with incident chronic kidney disease. METHODS: We measured plasma suPAR levels in 3683 persons enrolled in the Emory Cardiovascular Biobank (mean age, 63 years; 65% men; median suPAR level, 3040 pg per milliliter) and determined renal function at enrollment and at subsequent visits in 2292 persons. The relationship between suPAR levels and the eGFR at baseline, the change in the eGFR over time, and the development of chronic kidney disease (eGFR <60 ml per minute per 1.73 m(2) of body-surface area) were analyzed with the use of linear mixed models and Cox regression after adjustment for demographic and clinical variables. RESULTS: A higher suPAR level at baseline was associated with a greater decline in the eGFR during follow-up; the annual change in the eGFR was -0.9 ml per minute per 1.73 m(2) among participants in the lowest quartile of suPAR levels as compared with -4.2 ml per minute per 1.73 m(2) among participants in the highest quartile (P<0.001). The 921 participants with a normal eGFR (≥ 90 ml per minute per 1.73 m(2)) at baseline had the largest suPAR-related decline in the eGFR. In 1335 participants with a baseline eGFR of at least 60 ml per minute per 1.73 m(2), the risk of progression to chronic kidney disease in the highest quartile of suPAR levels was 3.13 times as high (95% confidence interval, 2.11 to 4.65) as that in the lowest quartile. CONCLUSIONS: An elevated level of suPAR was independently associated with incident chronic kidney disease and an accelerated decline in the eGFR in the groups studied. (Funded by the Abraham J. and Phyllis Katz Foundation and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213
Uno, H., Cai, T., Pencina, M. J., D'Agostino, R. B., & Wei, L. J. (2011) · Statistics in Medicine · doi:10.1002/sim.4154 · Cited by 1,535
Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241
Wolf, G., Chen, S., Han, D. C., & Ziyadeh, F. N. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.29865 · Cited by 871
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Wei, C., El Hindi, S., Li, J., Fornoni, A., Goes, N., Sageshima, J., Maiguel, D., Karumanchi, S. A., Yap, H.-K., Saleem, M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2411 · Cited by 841
Self-citationThe Womenʼs Interagency HIV Study
Barkan, S. E., Melnick, S. L., Preston-Martin, S., Weber, K., Kalish, L. A., Miotti, P., Young, M., Greenblatt, R., Sacks, H., & Feldman, J. (1998) · Epidemiology · doi:10.1097/00001648-199803000-00004 · Cited by 814
Do We Still Need a Cohort Study of Women with HIV Infection?
&NA; (1998) · Epidemiology · doi:10.1097/00001648-199803000-00001 · Cited by 728
Early recognition and prevention of chronic kidney disease
James, M. T., Hemmelgarn, B. R., & Tonelli, M. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62004-3 · Cited by 606
suPAR: The Molecular Crystal Ball
Thunø, M., Macho, B., & Eugen-Olsen, J. (2009) · Disease Markers · doi:10.1155/2009/504294 · Cited by 548
Modification of kidney barrier function by the urokinase receptor
Wei, C., Möller, C. C., Altintas, M. M., Li, J., Schwarz, K., Zacchigna, S., Xie, L., Henger, A., Schmid, H., Rastaldi, M. P., et al. (2008) · Nature Medicine · doi:10.1038/nm1696 · Cited by 523
Self-citationBiomarkers in chronic kidney disease: a review
Fassett, R. G., Venuthurupalli, S. K., Gobe, G. C., Coombes, J. S., Cooper, M. A., & Hoy, W. E. (2011) · Kidney International · doi:10.1038/ki.2011.198 · Cited by 449
Combining GFR and Albuminuria to Classify CKD Improves Prediction of ESRD
Hallan, S. I., Ritz, E., Lydersen, S., Romundstad, S., Kvenild, K., & Orth, S. R. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070730 · Cited by 439
Eugen‐Olsen, J., Andersen, O., Linneberg, A., Ladelund, S., Hansen, T. W., Langkilde, A., Petersen, J., Pielak, T., Møller, L. N., Jeppesen, J., et al. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02252.x · Cited by 383
Structure of Human Urokinase Plasminogen Activator in Complex with Its Receptor
Huai, Q., Mazar, A. P., Kuo, A., Parry, G. C., Shaw, D. E., Callahan, J., Li, Y., Yuan, C., Bian, C., Chen, L., et al. (2006) · Science · doi:10.1126/science.1121143 · Cited by 308
Levey, A. S., Cattran, D., Friedman, A., Miller, W. G., Sedor, J., Tuttle, K., Kasiske, B., & Hostetter, T. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.04.029 · Cited by 298
Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction
Wang, T. J. (2011) · Circulation · doi:10.1161/circulationaha.109.912568 · Cited by 294
Backes, Y., van der Sluijs, K. F., Mackie, D. P., Tacke, F., Koch, A., Tenhunen, J. J., & Schultz, M. J. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2613-1 · Cited by 268
Delville, M., Sigdel, T. K., Wei, C., Li, J., Hsieh, S.-C., Fornoni, A., Burke, G. W., Bruneval, P., Naesens, M., Jackson, A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008538 · Cited by 232
Self-citationClinical significance of urokinase‐type plasminogen activator receptor (uPAR) expression in cancer
de Bock, C. E., & Wang, Y. (2003) · Medicinal Research Reviews · doi:10.1002/med.10054 · Cited by 153
Yoo, T., Pedigo, C. E., Guzman, J., Correa-Medina, M., Wei, C., Villarreal, R., Mitrofanova, A. V., Leclercq, F., Faul, C., Li, J., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111213 · Cited by 152
Self-citationEapen, D. J., Manocha, P., Ghasemzadeh, N., Patel, R. S., Kassem, H. A., Hammadah, M., Veledar, E., Le, N., Pielak, T., Thorball, C. W., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001118 · Cited by 146
Self-citationLyngbæk, S., Marott, J. L., Sehestedt, T. B., Hansen, T. W., Olsen, M. H., Andersen, O., Linneberg, A. R., Haugaard, S. B., Eugen‐Olsen, J., Hansen, P. R., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.07.018 · Cited by 143
Andersen, O., Eugen‐Olsen, J., Kofoed, K., Iversen, J., & Haugaard, S. B. (2007) · Journal of Medical Virology · doi:10.1002/jmv.21114 · Cited by 132
A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
Spinale, J. M., Mariani, L. H., Kapoor, S. C., Zhang, J., Weyant, R., Song, P. X. ‐., Wong, H. N., Troost, J. P., Gadegbeku, C. A., Gipson, D. S., et al. (2014) · Kidney International · doi:10.1038/ki.2014.346 · Cited by 124
The urokinase system in the pathogenesis of atherosclerosis
Fuhrman, B. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.044 · Cited by 118
Hessol, N. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.6.563 · Cited by 100
Sier, C. F. M., Sidénius, N., Mariani, A., Aletti, G. D., Agape, V., Ferrari, A. G., Casetta, G., Stephens, R. W., Brünner, N., & Blasi, F. (1999) · PubMed · Cited by 88
Theilade, S., Lyngbæk, S., Hansen, T. W., Eugen‐Olsen, J., Fenger, M., Rossing, P. R., & Jeppesen, J. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12269 · Cited by 82
Evidence‐based guide to slowing the progression of early renal insufficiency
Johnson, D. W. (2004) · Internal Medicine Journal · doi:10.1111/j.1444-0903.2004.t01-6-.x · Cited by 78
Borné, Y., Persson, M., Melander, O., Smith, J. G., & Engström, G. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.49 · Cited by 66
Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease
Meijers, B. K. I., Poesen, R., Claes, K. J., Dietrich, R., Bammens, B., Sprangers, B., Naesens, M., Storr, M., Kuypers, D. R. J., & Evenepoel, P. (2014) · Kidney International · doi:10.1038/ki.2014.197 · Cited by 66
C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study
Jeppesen, J., Hansen, T. W., Olsen, M. H., Rasmussen, S. L., lbsen, H., Torp-Pedersen, C. T., Hildebrandt, P. R., & Madsbad, S. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328308bb8b · Cited by 62
Maile, L. A., Busby, W. H., Gollahon, K. A., Flowers, W. L., Garbacik, N., Garbacik, S. R., Stewart, K. R., Nichols, T. C., Bellinger, D. A., Patel, A., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1318 · Cited by 54
Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels
Gustafsson, A., Ajeti, V., & Ljunggren, L. (2011) · Biomarker Insights · doi:10.4137/bmi.s8326 · Cited by 54
BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats
Maile, L. A., Gollahon, K. A., Wai, C., Dunbar, P. R., Busby, W. H., & Clemmons, D. R. (2014) · Journal of Diabetes Research · doi:10.1155/2014/421827 · Cited by 26
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Senolytic CAR T cells reverse senescence-associated pathologies
Amor, C., Feucht, J., Leibold, J., Ho, Y.-J., Zhu, C., Alonso-Curbelo, D., Mansilla-Soto, J., Boyer, J. A., Li, X., Giavridis, T., et al. (2020) · Nature · doi:10.1038/s41586-020-2403-9 · Cited by 1,098
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753
Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
Mihai, S., Codrici, E., Popescu, I. D., Enciu, A.-M., Albulescu, L., Necula, L. G., Mambet, C., Anton, G., & Tanase, C. (2018) · Journal of Immunology Research · doi:10.1155/2018/2180373 · Cited by 673
Idiopathic nephrotic syndrome in children
Noone, D. G., Iijima, K., & Parekh, R. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30536-1 · Cited by 586
Metadata
- Authors
- Hayek, S. S., Sever, S., Ko, Y.-A., Trachtman, H., Awad, M., Wadhwani, S., Altintas, M. M., Wei, C., Hotton, A. L., French, A. L., Sperling, L. S., Lerakis, S., Quyyumi, A. A., & Reiser, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-11-12
- Volume
- 373
- Issue
- 20
- Pages
- 1916-1925
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2195506720
- Cited by
- 427
- References
- 39
- FWCI
- 29.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.